A study found that treatment with CXCL12 prompted CTLs to leave cutaneous tumors via lymphatic vessels (137), whereas suppression of CXCL12 expression in senescent tumor cells enhanced T cell infiltration in colonic tumors (138). The gene discussed is CXCL12; the disease is neoplasm.